Why Early Diagnosis of PAH is So ImportantIncreasing awareness of pulmonary arterial hypertension (PAH) is crucial for early diagnosis and better patient management.
Merck Drug for Heart and Lung Disorder Wins a First-in-Class FDA ApprovalPulmonary arterial hypertension (PAH) is a rare form of hypertension affecting lung arteries, leading to heart problems.FDA approved a new Merck drug, Winrevair (sotatercept), which targets an underlying cause of PAH and helps alleviate symptoms.